Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page

Natco Pharma’s Q4 net profit sees 5% year-over-year increase, reaching ₹406 crore.

by Team Small News | May 30, 2025 | Natco, Pharma

Natco Pharma Ltd, an Indian multinational pharmaceutical company, reported a 5% increase in consolidated net profit for the quarter ended March 31, 2025, with a net profit of ₹406 crore compared to ₹386.3 crore in the same period last year. The company’s...
Unlocking the Emerging Opportunities in India’s Pharmaceutical Industry

Unlocking the Emerging Opportunities in India’s Pharmaceutical Industry

by Team Small News | May 22, 2025 | Aurobindo Pharma, Natco, Pharma, Piramal Pharma, Zydus

The Indian pharmaceutical sector has demonstrated robust growth over the past year, driven by a new trade agreement with the European Union that reduces tariffs on key drug exports. This agreement is expected to enhance India’s position as a global supplier of...

SMA patients welcome Natco’s development of a generic drug, calling on the government to ensure timely access to it.

by Team Small News | Apr 12, 2025 | Natco, Pharma

The article reports on the recent development of a generic drug by Natco Pharmaceuticals, a leading Indian pharmaceutical company, which is expected to benefit patients suffering from Spinal Muscular Atrophy (SMA). SMA is a genetic disorder that affects the muscles,...

Patents for Pharmaceuticals: Balancing Exclusive Rights with Public Welfare

by Team Small News | Apr 9, 2025 | Natco, Pharma

The Indian court, Justice Mini Pushkarna, recently ruled against granting an injunction in favor of Roche, a pharmaceutical company, in a landmark case involving the patent dispute over the drug Risdiplam, used to treat Spinal Muscular Atrophy (SMA). The court’s...

Natco Pharma’s Executive Vice President of Technology Transfer, Intellectual Property Rights and Regulatory Affairs, Dr Ramesh Dandala, retires.

by Team Small News | Apr 5, 2025 | Natco, Pharma

A Senior Executive at Natco Pharma Retires Natco Pharma, a leading Indian pharmaceutical company, has announced the superannuation of Dr. Ramesh Dandala, the Executive Vice President of Technology Transfer, Intellectual Property Rights & Regulatory Affairs (API)....

Delhi High Court orders Natco Pharma to put risk of launching novel spinal medication Risdiplam on hold in light of patent infringement controversy.

by Team Small News | Mar 27, 2025 | Natco, Pharma

The Delhi High Court has ordered Natco Pharma to pause the launch of a generic version of Roche’s rare disease drug, Risdiplam, amid a patent dispute. The court has restrained Natco Pharma from launching the generic version of the drug, which is used to treat...
« Older Entries

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress